{
    "nctId": "NCT03091842",
    "briefTitle": "Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer",
    "officialTitle": "Taking AIM at Breast Cancer: Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer Survivors",
    "overallStatus": "WITHDRAWN",
    "conditions": "Cancer Survivor, Central Obesity, Estrogen Receptor Positive, Postmenopausal, Progesterone Receptor Positive, Stage I Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIA Breast Cancer, Stage IIB Breast Cancer, Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "SUPPORTIVE_CARE",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Reduction of adipose tissue inflammation assessed by measuring M1 and M2 adipose tissue macrophages, crown-like structures, and adipose tissue secretion levels of inflammatory cytokines secreted",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Postmenopausal (at time of diagnosis; including artificial menopause induced by previous hysterectomy) women newly diagnosed (stage I-III) breast cancer low grade disease positive for estrogen and progesterone receptors\n* Are centrally obese with the following criteria (determined by study team at eligibility screening): body mass index (BMI) \\> 30 kg/m\\^2 (calculated using height and weight; an upper limit BMI will not be set; we will rely on obtaining physicians' clearance to assess full eligibility) or body fat \\> 30% (estimated by bioelectrical impedance), and waist circumference \\> 35 inches (in)\n* Have undergone a lumpectomy or mastectomy\n* Have received and completed neoadjuvant or adjuvant chemotherapy and/or radiation therapy within the past 12 months\n* Speak English or Spanish\n* Is in breast cancer remission with no detectable disease present\n* Able to initiate a supervised exercise program (free from any cardiovascular, respiratory or musculoskeletal disease or joint problems that preclude moderate physical activity)\n* Free from history of chronic disease including uncontrolled diabetes, hypertension or thyroid disease\n* Have not experienced a weight reduction \\>= 10% within past 6 months\n* Currently participate in less than 60 minutes of structured exercise/week\n* No planned reconstructive surgery with flap repair during trial and follow-up period\n* May use adjuvant endocrine therapy if use will be continued for duration of study intervention\n* Does not smoke (no smoking during previous 12 months)\n* Willing to travel to the exercise facility at University of Southern California (USC)\n\nExclusion Criteria:\n\n* Patients with metastatic disease\n* Is not centrally obese\n* Has not completed surgery, chemotherapy, or radiation treatment associated with their diagnosis\n* History of any musculoskeletal, cardiorespiratory or neurological diseases that preclude the participation in exercise\n* Participates in more than 60 minutes of structured exercise/week\n* Is planning reconstructive surgery with flap repair during trial and follow-up period\n* Currently smokes\n* Is unable to travel to the exercise facility at USC",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}